We are live on ! Find out more
XBIT icon

XBiotech
XBIT

65 hedge funds and large institutions have $74.1M invested in XBiotech in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $62.6M → $74.1M (+$11.6M)

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

1.02% more ownership

Funds ownership: 13.66% → 14.68% (+1%)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

2% less funds holding

Funds holding: 66 → 65 (-1)

81% less call options, than puts

Call options by funds: $245K | Put options by funds: $1.29M

Holders
65
Holders Change
-1
Holders Change %
-1.52%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
22
Reduced
19
Closed
10
Calls
$245K
Puts
$1.29M
Net Calls
-$1.04M
Net Calls Change
-$83K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$2.12M
2
State Street
State Street
Massachusetts
+$2.06M
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.3M
4
BlackRock
BlackRock
New York
+$1,000K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$613K

Top Sellers

Rank Fund Capital Flow
1
CCM
CAAS Capital Management
New York
-$1.5M
2
Northern Trust
Northern Trust
Illinois
-$1.16M
3
VI
Vestcor Inc
New Brunswick, Canada
-$303K
4
TNB
Thomasville National Bank
Georgia
-$218K
5
Morgan Stanley
Morgan Stanley
New York
-$203K

XBIT Hedge Fund Activity: Q1 2021 in Review

65 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2021, worth a combined $74.1M — up 18% from $62.6M a quarter earlier.

Fund positioning in XBIT was balanced in Q1 2021: 10 funds opened new positions, 10 closed out, 22 added to existing stakes and 19 trimmed.

The largest buyer was Wells Fargo, adding an estimated $2.12M. The largest seller was CAAS Capital Management, cutting an estimated $1.5M.

  • 65 institutional investors held XBiotech (XBIT) as of Q1 2021, down from 66 in Q4 2020.
  • Funds reported $74.1M of XBiotech stock for Q1 2021, up 18% quarter-over-quarter.
  • 10 funds opened new XBiotech positions in Q1 2021 and 10 closed out, a net change of 0 holders.
  • The largest XBiotech buyer in Q1 2021 was Wells Fargo, an estimated $2.12M added.
  • The largest XBiotech seller in Q1 2021 was CAAS Capital Management, an estimated $1.5M sold.

Based on aggregated 13F filings for Q1 2021.